Search
Research
Species-Specific and Cross-Reactive IgG1 Antibody Binding to Viral Capsid Protein 1 (VP1) Antigens of Human Rhinovirus Species A, B and CHuman rhinoviruses (HRV) are associated with upper and lower respiratory illnesses, including severe infections causing hospitalization in both children...
Research
Determinants of attenuation in the envelope protein of the flavivirus AlfuyMurray Valley encephalitis virus (MVEV) is a mosquito-borne flavivirus endemic to Australia and Papua New Guinea.
Research
Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World PerspectiveThis review supports the recommended use of palivizumab for reducing RSV-associated hospitalisation rates in premature babies born at gestational age <33 weeks.
Research
Is Streptococcus pyogenes resistant or susceptible to trimethoprim-sulfamethoxazole?Streptococcus pyogenes is commonly believed to be resistant to trimethoprim-sulfamethoxazole (SXT), resulting in reservations about using SXT for skin and...
News & Events
Trans Tasman action to fast track rheumatic fever vaccinePrime Ministers of Australia and New Zealand have agreed to provide $3M to help fast-track the development of a vaccine against rheumatic fever.
News & Events
Investigational vaccine for WA's meningococcal threatPerth researchers have begun a clinical trial of an investigational Meningococcal B vaccine against the most common form of meningococcal disease in W.A.
News & Events
Potential new vaccine for WA's meningococcal threatPerth researchers are trialling a Meningococcal B vaccine that could potentially provide protection
News & Events
Beating the flu bugPerth children are being asked to volunteer for an important national study to test the effectiveness of an influenza vaccine in children.
News & Events
Children sought for study into how to prevent sore throatsMore than 1000 children are being sought for a study to learn more about sore throats and how best to prevent them.
News & Events
BHP commits $2.6 million to research focused on stopping COVID-19 spreadResearchers from The Kids Research Institute Australia will lead a world first trial to test the effectiveness of the drug interferon in stopping outbreaks of COVID-19 by reducing the infectiousness of people who contract the virus.